These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 14532199)

  • 1. Decreased vancomycin susceptibility of coagulase-negative staphylococci in a neonatal intensive care unit: evidence of spread of Staphylococcus warneri.
    Center KJ; Reboli AC; Hubler R; Rodgers GL; Long SS
    J Clin Microbiol; 2003 Oct; 41(10):4660-5. PubMed ID: 14532199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends of Antimicrobial Susceptibility in Clinically Significant Coagulase-Negative Staphylococci Isolated from Cerebrospinal Fluid Cultures in Neurosurgical Adults: a Nine-Year Analysis.
    Ye Y; Tian Y; Kong Y; Ma J; Shi G
    Microbiol Spectr; 2022 Feb; 10(1):e0146221. PubMed ID: 35138154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Impact of Vancomycin MIC on Outcomes in Patients With Coagulase-negative Staphylococcal Bacteremia.
    Wheat W; Simiyu B; Andonie G; Bellfi L
    Clin Ther; 2024 Jun; 46(6):444-450. PubMed ID: 38493003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First report of vancomycin-resistant staphylococci isolated from healthy carriers in Brazil.
    Palazzo IC; Araujo ML; Darini AL
    J Clin Microbiol; 2005 Jan; 43(1):179-85. PubMed ID: 15634969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefazolin susceptibility of coagulase-negative staphylococci (CoNS) causing late-onset neonatal bacteraemia.
    Marr I; Swe K; Henderson A; Lacey JA; Carter GP; Ferguson JK
    J Antimicrob Chemother; 2022 Feb; 77(2):338-344. PubMed ID: 34791307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vancomycin resistance in staphylococci.
    Srinivasan A; Dick JD; Perl TM
    Clin Microbiol Rev; 2002 Jul; 15(3):430-8. PubMed ID: 12097250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methicillin-resistant Staphylococcus capitis with reduced vancomycin susceptibility causes late-onset sepsis in intensive care neonates.
    Rasigade JP; Raulin O; Picaud JC; Tellini C; Bes M; Grando J; Ben Saïd M; Claris O; Etienne J; Tigaud S; Laurent F
    PLoS One; 2012; 7(2):e31548. PubMed ID: 22348102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No survival benefit with empirical vancomycin therapy for coagulase-negative staphylococcal bloodstream infections in infants.
    Ericson JE; Thaden J; Cross HR; Clark RH; Fowler VG; Benjamin DK; Cohen-Wolkowiez M; Hornik CP; Smith PB;
    Pediatr Infect Dis J; 2015 Apr; 34(4):371-5. PubMed ID: 25760564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of clones of coagulase-negative staphylococci among premature neonates in neonatal intensive care units: two-center study of bacterial genotyping and patient risk factors.
    Vermont CL; Hartwig NG; Fleer A; de Man P; Verbrugh H; van den Anker J; de Groot R; van Belkum A
    J Clin Microbiol; 1998 Sep; 36(9):2485-90. PubMed ID: 9705379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and pathogenicity of multidrug-resistant coagulase-negative Staphylococci isolates in chickens.
    Sorour HK; Shalaby AG; Abdelmagid MA; Hosny RA
    Int Microbiol; 2023 Nov; 26(4):989-1000. PubMed ID: 37055707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Epidemiology of Neonatal-Associated Staphylococcus haemolyticus Reveals Endemic Outbreak.
    Westberg R; Stegger M; Söderquist B
    Microbiol Spectr; 2022 Dec; 10(6):e0245222. PubMed ID: 36314976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should First-line Empiric Treatment Strategies for Neonates Cover Coagulase-negative Staphylococcal Infections in Kenya?
    Seale AC; Obiero CW; Jones KD; Barsosio HC; Thitiri J; Ngari M; Morpeth S; Mohammed S; Fegan G; Mturi N; Berkley JA
    Pediatr Infect Dis J; 2017 Nov; 36(11):1073-1078. PubMed ID: 28731901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The MIC distribution of dalbavancin differs between different coagulase-negative staphylococci.
    Svensson S; Hagstedt P; Söderquist B
    JAC Antimicrob Resist; 2024 Apr; 6(2):dlae063. PubMed ID: 38601789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucoid Staphylococcus haemolyticus: an unheeded multidrug-resistant pathogen.
    Singhal L; Gupta V; Sharma S; Agarwal A; Gupta P
    Braz J Microbiol; 2023 Mar; 54(1):191-198. PubMed ID: 36680660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daptomycin Use for Persistent Coagulase-Negative Staphylococcal Bacteremia in a Neonatal Intensive Care Unit.
    Papachatzi E; Gkentzi D; Tzifas S; Dassios T; Dimitriou G
    Antibiotics (Basel); 2024 Mar; 13(3):. PubMed ID: 38534689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heteroresistant Vancomycin Intermediate Coagulase Negative Staphylococcus in the NICU: A Systematic Review.
    Chong J; Caya C; Lévesque S; Quach C
    PLoS One; 2016; 11(10):e0164136. PubMed ID: 27716838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newly identified pathogens in periodontitis: evidence from an association and an elimination study.
    Veras EL; Castro Dos Santos N; Souza JGS; Figueiredo LC; Retamal-Valdes B; Barão VAR; Shibli J; Bertolini M; Faveri M; Teles F; Duarte P; Feres M
    J Oral Microbiol; 2023; 15(1):2213111. PubMed ID: 37261036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vancomycin heteroresistance among methicillin-resistant clinical isolates S. haemolyticus, S. hominis, S. simulans, and S. warneri.
    Szemraj M; Lisiecki P; Glajzner P; Szewczyk EM
    Braz J Microbiol; 2023 Mar; 54(1):159-167. PubMed ID: 36374479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daptomycin for Treatment of
    Minotti C; Zuccon I; Priante E; Bonadies L; Di Chiara C; Donà D; Baraldi E; Costenaro P
    Children (Basel); 2022 Mar; 9(4):. PubMed ID: 35455502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vancomycin Use in Children and Neonates across Three Decades: A Bibliometric Analysis of the Top-Cited Articles.
    Minotti C; Barbieri E; Giaquinto C; Donà D
    Pathogens; 2021 Oct; 10(10):. PubMed ID: 34684291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.